Characterization of Epstein-Barr virus genotype in AIDS-related non-Hodgkin’s lymphoma

AIDS Research and Human Retroviruses

Volumn 18, Issue 1, 2002, Pages 19-26

  Fassone, Lucia ^a   Cingolani, Antonella ^b   Martini, Maurizio ^b   Migliaretti, Giuseppe ^c   Oreste, Pier Luigi ^d   Capello, Daniela ^a   Gloghini, Annunziata ^e   Vivenza, Daniela ^a   Dolcetti, Riccardo ^e   Carbone, Antonino ^e   Antinori, Andrea ^f   Gaidano, Gianluca ^a   Larocca, Luigi Maria ^b  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d Division of Infectious Disease   (Italy)

^e CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^f NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; EPSTEIN BARR VIRUS ANTIGEN; LATENT MEMBRANE PROTEIN 1; LEUCINE; PROLINE; THREONINE; VALINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BURKITT LYMPHOMA; CARBOXY TERMINAL SEQUENCE; CELL COUNT; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DISEASE TRANSMISSION; EPSTEIN BARR VIRUS; FEMALE; GENE DELETION; GENETIC CODE; GENOTYPE; HISTOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE DEFICIENCY; IMMUNOCOMPETENCE; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SAMPLING; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; VIRUS CHARACTERIZATION; VIRUS DETECTION; VIRUS IDENTIFICATION; VIRUS STRAIN;

AMINO ACID SEQUENCE; ANTIGENS, VIRAL; BURKITT LYMPHOMA; CARRIER PROTEINS; CD4 LYMPHOCYTE COUNT; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; GENE DELETION; GENOTYPE; HERPESVIRUS 4, HUMAN; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOMA, AIDS-RELATED; LYMPHOMA, LARGE-CELL, DIFFUSE; LYMPHOMA, NON-HODGKIN; MOLECULAR SEQUENCE DATA; RISK FACTORS; SEQUENCE ALIGNMENT; VIRAL PROTEINS; ZINC FINGERS;

EID: 0036172644     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922202753394682     Document Type: Article

References (29)

1. Epstein-Barr virus
2. Are particular Epstein-Barr virus strains linked to disease?
3. Epstein-Barr virus strain characterization
4. Molecular epidemiology of Epstein-Barr virus infection
5. Epidemiology of infection with Epstein-Barr virus types 1 and 2: Lessons from the study of a T-cell-immunocompromised hemophilic cohort
6. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells
7. Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from the nasopharingeal carcinoma in the Taiwanese population
8. Deletions within the LMP-1 oncogene of Epstein-Barr virus are clustered in Hodgkin’s disease and identical to those observed in nasopharingeal carcinoma
9. Biologically relevant phenotypic changes and enhanced growth properties induced in B lymphocytes by an EBV strain derived from a histologically aggressive Hodgkin’s disease
10. Variation in the sequence of Epstein-Barr virus nuclear antigen 1 in normal peripheral blood lymphocytes and in Burkitt’s lymphomas
11. Sequence variations in EBNA-1 may dictate restriction of tissue distribution of Epstein-Barr virus in normal and tumour cells
12. Epstein-Barr virus-associated nuclear antigen-1 carboxy-terminal gene sequences in Japanese and American patients with gastric carcinoma
13. Epstein-Barr virus nuclear antigen 1 sequences in endemic and sporadic Burkitt’s lymphoma reflect virus strains prevalent in different geographic areas
14. EBNA-1 gene sequences in Brazilian and American patients with Hodgkin’s disease
15. Molecular profile of Epstein-Barr virus infection in HHV-8-positive primary effusion lymphoma
16. DNA sequence and expression of the B95-8 Epstein-Barr virus genome
17. Epstein-Barr virus latent membrane protein-1 oncogene deletions: Correlations with malignancy in Epstein-Barr virus-associated lymphoproliferative disorders and malignant lymphomas
18. Analysis of Epstein-Barr virus gene polymorphisms in normal donors and in virus-associated tumors from different geographic locations
19. The molecular and phenotypic profile of central nervous system lymphoma identifies distinct categories of the disease and is consistent with histogenesis derivation from germinal center-related B cells
20. Analysis of Epstein-Barr virus (EBV) nuclear antigen 1 subtypes in EBV associated lymphomas from Brazil and the United Kingdom
21. The molecular epidemiology and evolution of Epstein-Barr virus: Sequence variation and genetic recombination in the latent membrane protein-1 gene
22. Sequence variation in the Epstein-Barr virus latent membrane protein 1
23. Pathogenesis of AIDS-related lymphomas. Molecular and histogenetic heterogeneity
24. Reed-Sternberg cells and "bystander" lymphocytes in lymph nodes affected by Hodgkin’s disease are infected with different strains of Epstein-Barr virus
25. Epstein-Barr virus in nasal lymphomas contain multiple ongoing mutations in the EBNA-1 gene
26. Incorporation into DNA of the base analog-2-aminopurine by the Epstein-Barr virus-induced DNA polymerase in vivo and in vitro
27. Epstein-Barr virus strains with latent membrane protein-1 deletions: Prevalence in the Italian population and high association with human immunodeficiency virus-related Hodgkin’s disease
28. Deletions within the Epstein-Barr virus latent membrane protein-1 oncogene in adult ordinary, HIV-associated and paediatric Hodgkin’s disease
29. The oncogenic 30 and 69 bp deletion variants of the EBV LMP-1 gene are common in HIV-negative lymphoproliferations, both malignant and benign